General Healthcare

Professor Mark Lawler explores working closely with communities, tailoring approaches for different populations, recruiting celebrities for awareness campaigns, and the impact of COVID-19 on oncology.

This episode, funded by a grant from Philips, explores physiology as a guidance tool to improve the practice and outcomes of coronary intervention.

Jonathan is joined by Norvell ‘Van’ Coots, President and CEO, Holy Cross Health. Together, they reflect on his start in dermatology, his service in the US military, and the promising rise of telemedicine in bringing patient care closer to home and into the community.

James Carroll explores the clinical applications of laser therapy, his journey into entrepreneurship, and considers what the future of healthcare might look like.

Jonathan sits down with Professor Michael Barnes, Chief Medical Officer, Lyphe Group and Director, Maple Tree Consultancy, to explore the subject of medicinal cannabis.

This episode, sponsored by Veracyte, is an overview of the European Breast Cancer Congress symposium ‘The Pathway to the Future of Breast Cancer Care’,

In the final episode of 2020, Jonathan takes a moment to consider how much the healthcare landscape has changed in light of COVID-19.

Jonathan and Ganapathy explore why India is the perfect case study for telemedicine, the importance of garnering support for telehealth from governments and policymakers, as well as his future outlook for aviation and space medicine.